suggests

Does genetics determine your reaction to psychedelics?  A recent study suggests that they could

Does genetics determine your reaction to psychedelics? A recent study suggests that they could

Research on psychedelics like LSD and psilocybin as treatments for substance use disorders, depression, anxiety, and PTSD holds incredible promise. The evidence is so compelling that some states are decriminalizing possession of these drugs and legalizing their therapeutic use, even though they remain under the federal government’s Schedule 1 classification. New drugs for mental health …

Does genetics determine your reaction to psychedelics? A recent study suggests that they could Read More »

Promising study suggests AAV-based gene therapy can treat type I glutaric aciduria

Promising study suggests AAV-based gene therapy can treat type I glutaric aciduria

Treatment of glutaric aciduria type I (GA-I) by intracerebroventricular administration of GCDH. Credit: Institute of Zoology, Chinese Academy of Sciences, China Glutaric aciduria type I (GA-I) is an inherited disease caused by a mutation in the glutaryl-CoA dehydrogenase (GCDH) gene. The global incidence of GA-I is estimated at 1/100,000, with approximately 75,000 cases worldwide. Patients …

Promising study suggests AAV-based gene therapy can treat type I glutaric aciduria Read More »